Real-time enrollment status for this cerebral adrenoleukodystrophy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:25 AM UTC
| NCT Number | NCT05819866 |
| Recruiting Status | Recruiting |
| Condition | Cerebral Adrenoleukodystrophy |
| Phase | Clinical Trial |
| Target Enrollment | 40 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Minoryx Therapeutics, S.L. |
| Last Updated on CT.gov | November 17, 2025 (Nov 17, 2025) |
As of March 2, 2026: Clinical trial NCT05819866 is currently recruiting participants. This clinical trial study for cerebral adrenoleukodystrophy is actively seeking new participants at 6 locations across the United States. The study is sponsored by Minoryx Therapeutics, S.L.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05819866 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05819866 was last updated Nov 17, 2025 (November 17, 2025). HelloStudys verifies this status automatically.